470 results on '"Tesař, Vladimír"'
Search Results
202. Study of urinary proteomes in Anderson-Fabry disease
203. Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats
204. Genetic Predisposition to Advanced Glycation End Products Toxicity Is Related to Prognosis of Chronic Hemodialysis Patients
205. Plasma calprotectin in chronically dialyzed end-stage renal disease patients
206. Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice
207. Cardiovascular issues of dialysis patients referred for ultrasound examination of vascular access grafts
208. Monocyte ‘Reprogramming’ and Mortality in Septic Patients with Acute Kidney Injury
209. Circulating Endothelial Progenitor Cells in Patients with ANCA-Associated Vasculitis
210. Recent Progress in the Pathogenesis of Nephrotic Proteinuria
211. The Roles of Intrarenal 20-Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acids in the Regulation of Renal Function in Hypertensive Ren-2 Transgenic Rats
212. 25th Annual Meeting of the International Society of Blood Purification (ISBP)
213. Does Renal Function Influence Plasma Levels of Advanced Glycation and Oxidation Protein Products in Patients with Chronic Rheumatic Diseases Complicated by Secondary Amyloidosis?
214. AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension
215. Late-Onset Endothelin-A Receptor Blockade Reduces Podocyte Injury in Homozygous Ren-2 Rats Despite Severe Hypertension
216. Effect of Hemodiafiltration on Pregnancy-Associated Plasma Protein A (PAPP-A) and Related Parameters
217. Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease
218. Blockade of Endothelin Receptors Attenuates End-Organ Damage in Homozygous Hypertensive Ren-2 Transgenic Rats
219. Antiphospholipid Antibodies in Patients with Lupus Nephritis
220. Advanced Glycation End Products in Hemodialyzed Patients with Diabetes Mellitus Correlate with Leptin and Leptin/Body Fat Ratio
221. INFLUENCE OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE POLYMORPHISM ON THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND IgA NEPHROPATHY
222. Endothelial Nitric Oxide Synthase Affects the Progression of Autosomal Dominant Polycystic Kidney Disease
223. Search for a balance between changing requirements for benefits from the forest and its condition in the Moravian-Silesian Beskids (Czech Republic)
224. Transjugular Renal Biopsy
225. Proteinurie.
226. The Czech Society of Nephrology – An Introduction
227. ZÁNĚTLIVÝ PSEUDOTUMOR MOČOVÉHO MĚCHÝŘE JAKO PROJEV AKTIVITY U PACIENTKY S GRANULOMATÓZOU S POLYANGIITIDOU (WEGENEROVOU GRANULOMATÓZOU) ? MÉNĚ OBVYKLÁ MANIFESTACE ANCA? ASOCIOVANÉ VASKULITIDY.
228. Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.
229. The Protective Effects of Erythropoietin on Rat Glomerular Podocytes in Culture are Modulated by Extracellular Matrix Proteins.
230. Trace Elements in End-Stage Renal Disease
231. Použití léků vyvinutých pro jiné indikace v léčbě infekce covid-19.
232. Trace Elements in Hemodialysis and Continuous Ambulatory Peritoneal Dialysis Patients
233. The influence of cyclosporine on lipid peroxidation and superoxide dismutase in adriamycine nephropathy in rats
234. The Influence of Pefloxacine on Experimental Adriamycin-Induced Nephrotic Syndrome in Rats
235. Antioxidant Enzymes - Superoxide Dismutase and Glutathione Peroxidase - in Haemodialyzed Patients
236. Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study
237. Pregnancy-Associated Plasma Protein A as an Independent Mortality Predictor in Long-Term Hemodialysis Patients.
238. The Roles of Intrarenal 20-Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acids in the Regulation of Renal Function in Hypertensive Ren-2 Transgenic Rats.
239. Biosimilars and Renal Health Care in the Countries of Central and Eastern Europe.
240. Does Renal Function Influence Plasma Levels of Advanced Glycation and Oxidation Protein Products in Patients with Chronic Rheumatic Diseases Complicated by Secondary Amyloidosis?
241. Clinical Features, Outcomes, and Response to Corticosteroid Treatment of Acute Tubulointerstitial Nephritis: A Single-Centre Retrospective Cohort Study in the Czech Republic.
242. Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate.
243. Závěr z pracovního setkání zástupců neurologů, nefrologů, revmatologů, onkologů, pediatrů, gastroenterologů a dermatovenerologů k problematice biosimilars, které se konalo 24. 6. 2013.
244. Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications.
245. Zpráva ze sympózia společnosti Abbott Laboratories na kongresu ČNS konaného dne 15. 6. 2012.
246. Introduction.
247. Retinoic acid associates with mortality of patients on long-term hemodialysis.
248. Dosing of Aminoglycosides in Chronic Kidney Disease and End-Stage Renal Disease Patients Treated with Intermittent Hemodialysis.
249. Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring.
250. Advanced glycoxidation end products in chronic diseases—clinical chemistry and genetic background
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.